1	Paciente	paciente	NCCS000	C0030705	persona	0-8	400_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	400_QUEST_clinical_caseMIR	SENT1	-	-
3	50	50		-	-	12-14	400_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	400_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	20-22	400_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	23-27	400_QUEST_clinical_caseMIR	SENT1	-	-
7	ingresado	ingresar	VMP00SM	-	-	28-37	400_QUEST_clinical_caseMIR	SENT1	-	-
8	para	para	SPS00	C0521125	calificador	38-42	400_QUEST_clinical_caseMIR	SENT1	-	-
9	estudio	estudio	NCMS000	C0557651	medio_ambiente	43-50	400_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0332285	atributo	51-53	400_QUEST_clinical_caseMIR	SENT1	-	-
11	síndrome	síndrome	NCMS000	C0027726_1	trastorno_1	54-62	400_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	nefrótico	nefrótico		C0027726_2	trastorno_2	63-72	400_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
13	.	.	Fp	-	-	72-73	400_QUEST_clinical_caseMIR	SENT1	-	-

1	Se	se	P00CN000	-	-	74-76	400_QUEST_clinical_caseMIR	SENT2	-	-
2	realiza	realizar	VMIP3S0	-	-	77-84	400_QUEST_clinical_caseMIR	SENT2	-	-
3	biopsia	biopsia	NCFS000	C0194073_1	procedimiento_1	85-92	400_QUEST_clinical_caseMIR	SENT2	-	-
4	renal	renal	AQ0CS0	C0194073_2	procedimiento_2	93-98	400_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
5	con	con	SPS00	C0332287	atributo	99-102	400_QUEST_clinical_caseMIR	SENT2	-	-
6	los	el	DA0MP0	-	-	103-106	400_QUEST_clinical_caseMIR	SENT2	-	-
7	siguientes	siguiente	AQ0CP0	C0332282	atributo	107-117	400_QUEST_clinical_caseMIR	SENT2	-	-
8	hallazgos	hallazgo	NCMP000	C0243095	hallazgo	118-127	400_QUEST_clinical_caseMIR	SENT2	-	-
9	:	:	Fd	-	-	127-128	400_QUEST_clinical_caseMIR	SENT2	-	-
10	engrosamiento	engrosamiento	NCMS000	C0205400	hallazgo	129-142	400_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
11	uniforme	uniforme	AQ0CS0	C0205375	calificador	143-151	400_QUEST_clinical_caseMIR	SENT2	-	-
12	y	y	CC	C1706368	calificador	152-153	400_QUEST_clinical_caseMIR	SENT2	-	-
13	difuso	difuso	AQ0MS0	C0205219	calificador	154-160	400_QUEST_clinical_caseMIR	SENT2	-	-
14	de	de	SPS00	C0332285	atributo	161-163	400_QUEST_clinical_caseMIR	SENT2	-	-
15	la	el	DA0FS0	-	-	164-166	400_QUEST_clinical_caseMIR	SENT2	-	-
16	pared	pared	NCFS000	-	-	167-172	400_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
17	de	de	SPS00	C0332285	atributo	173-175	400_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
18	los	el	DA0MP0	-	-	176-179	400_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
19	capilares	capilar	NCMP000	C0226356_1	estructura_corporal_1	180-189	400_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
20	glomerulares	glomerular	AQ0CP0	C0226356_2	estructura_corporal_2	190-202	400_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
21	.	.	Fp	-	-	202-203	400_QUEST_clinical_caseMIR	SENT2	-	-

1	Con	con	SPS00	C0332287	atributo	204-207	400_QUEST_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	208-210	400_QUEST_clinical_caseMIR	SENT3	-	-
3	tinción	tinción	NCFS000	C0038128#C0013343	sustancia	211-218	400_QUEST_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	219-221	400_QUEST_clinical_caseMIR	SENT3	-	-
5	plata	plata	NCFS000	C0037125	sustancia	222-227	400_QUEST_clinical_caseMIR	SENT3	-	-
6	se	se	P00CN000	-	-	228-230	400_QUEST_clinical_caseMIR	SENT3	-	-
7	observan	observar	VMIP3P0	-	-	231-239	400_QUEST_clinical_caseMIR	SENT3	-	-
8	espiculas	espiculas	NCFP000	-	-	240-249	400_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
9	(	(	Fpa	-	-	250-251	400_QUEST_clinical_caseMIR	SENT3	-	-
10	spikes	spikes	NCMP000	-	-	251-257	400_QUEST_clinical_caseMIR	SENT3	-	-
11	)	)	Fpt	-	-	257-258	400_QUEST_clinical_caseMIR	SENT3	-	-
12	y	y	CC	C1706368	calificador	259-260	400_QUEST_clinical_caseMIR	SENT3	-	-
13	la	el	DA0FS0	-	-	261-263	400_QUEST_clinical_caseMIR	SENT3	-	-
14	inmunofluorescencia	inmunofluorescencia	NCFS000	C0079603	procedimiento	264-283	400_QUEST_clinical_caseMIR	SENT3	-	-
15	muestra	mostrar	VMIP3S0	-	-	284-291	400_QUEST_clinical_caseMIR	SENT3	-	-
16	depósitos	depósito	NCMP000	C0442627#C0333562	medio_ambiente#anomalía_morfológica	292-301	400_QUEST_clinical_caseMIR	SENT3	-	-
17	de	de	SPS00	C0332285	atributo	302-304	400_QUEST_clinical_caseMIR	SENT3	-	-
18	IgG	igg	NCMS000	-	-	305-308	400_QUEST_clinical_caseMIR	SENT3	-	-
19	y	y	CC	C1706368	calificador	309-310	400_QUEST_clinical_caseMIR	SENT3	-	-
20	C3	C3		-	-	311-313	400_QUEST_clinical_caseMIR	SENT3	-	-
21	a	a	SPS00	-	-	314-315	400_QUEST_clinical_caseMIR	SENT3	-	-
22	lo	lo	PP3CNA00	-	-	316-318	400_QUEST_clinical_caseMIR	SENT3	-	-
23	largo	largo	AQ0MS0	C0205166#C0392744	calificador	319-324	400_QUEST_clinical_caseMIR	SENT3	-	-
24	de	de	SPS00	C0332285	atributo	325-327	400_QUEST_clinical_caseMIR	SENT3	-	-
25	la	el	DA0FS0	-	-	328-330	400_QUEST_clinical_caseMIR	SENT3	-	-
26	pared	pared	NCFS000	-	-	331-336	400_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
27	capilar	capilar	AQ0CS0	C1280521#C0006901	estructura_corporal	337-344	400_QUEST_clinical_caseMIR	SENT3	I-Estructura_Corporal	-
28	.	.	Fp	-	-	344-345	400_QUEST_clinical_caseMIR	SENT3	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	346-348	400_QUEST_clinical_caseMIR	SENT4	-	-
2	suero	suero	NCMS000	C0229671#C0588987	sustancia#producto	349-354	400_QUEST_clinical_caseMIR	SENT4	-	-
3	se	se	P00CN000	-	-	355-357	400_QUEST_clinical_caseMIR	SENT4	-	-
4	detectan	detectar	VMIP3P0	-	-	358-366	400_QUEST_clinical_caseMIR	SENT4	-	-
5	autoanticuerpos	autoanticuerpo	NCMP000	C0004358	sustancia	367-382	400_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
6	circulantes	circulante	AQ0CP0	C0175630	calificador	383-394	400_QUEST_clinical_caseMIR	SENT4	I-Grp_Enfermedad	-
7	contra	contra	SPS00	C0521124	calificador	395-401	400_QUEST_clinical_caseMIR	SENT4	-	-
8	el	el	DA0MS0	-	-	402-404	400_QUEST_clinical_caseMIR	SENT4	-	-
9	receptor	receptor	NCMS000	C0597357	sustancia	405-413	400_QUEST_clinical_caseMIR	SENT4	-	-
10	tipo	tipo	NCMS000	C0332307	calificador#atributo	414-418	400_QUEST_clinical_caseMIR	SENT4	-	-
11	M	m	NCFS000	-	-	419-420	400_QUEST_clinical_caseMIR	SENT4	-	-
12	de	de	SPS00	C0332285	atributo	421-423	400_QUEST_clinical_caseMIR	SENT4	-	-
13	la	el	DA0FS0	-	-	424-426	400_QUEST_clinical_caseMIR	SENT4	-	-
14	fosfolipasa	fosfolipasa	NCFS000	C0031671	sustancia	427-438	400_QUEST_clinical_caseMIR	SENT4	-	-
15	A2	A2		-	-	439-441	400_QUEST_clinical_caseMIR	SENT4	-	-
16	(	(	Fpa	-	-	442-443	400_QUEST_clinical_caseMIR	SENT4	-	-
17	PLA2R	PLA2R		-	-	443-448	400_QUEST_clinical_caseMIR	SENT4	-	-
18	)	)	Fpt	-	-	448-449	400_QUEST_clinical_caseMIR	SENT4	-	-
19	.	.	Fp	-	-	449-450	400_QUEST_clinical_caseMIR	SENT4	-	-

1	La	el	DA0FS0	-	-	451-453	400_QUEST_clinical_caseMIR	SENT5	-	-
2	entidad	entidad	NCFS000	-	-	454-461	400_QUEST_clinical_caseMIR	SENT5	-	-
3	causante	causante	AQ0CS0	-	-	462-470	400_QUEST_clinical_caseMIR	SENT5	-	-
4	del	del	SP+DA	-	-	471-474	400_QUEST_clinical_caseMIR	SENT5	-	-
5	síndrome	síndrome	NCMS000	C0027726_1	trastorno_1	475-483	400_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
6	nefrótico	nefrótico		C0027726_2	trastorno_2	484-493	400_QUEST_clinical_caseMIR	SENT5	I-Grp_Enfermedad	-
7	en	en	SPS00	C1720294#C0332285	calificador#atributo	494-496	400_QUEST_clinical_caseMIR	SENT5	-	-
8	este	este	DD0MS0	-	-	497-501	400_QUEST_clinical_caseMIR	SENT5	-	-
9	paciente	paciente	NCCS000	C0030705	persona	502-510	400_QUEST_clinical_caseMIR	SENT5	-	-
10	es	ser	VSIP3S0	-	-	511-513	400_QUEST_clinical_caseMIR	SENT5	-	-
11	:	:	Fd	-	-	513-514	400_QUEST_clinical_caseMIR	SENT5	-	-
12	.	.	Fp	-	-	514-515	400_QUEST_clinical_caseMIR	SENT5	-	-

